Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by University of Pennsylvania
Sponsor:
Collaborator:
Children's Hospital of Philadelphia
Information provided by (Responsible Party):
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01851694
First received: May 8, 2013
Last updated: March 30, 2016
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)